Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activitya
aDetails for the preparation of the thiolactomycin analogues shown in Table 1 are available as supplementary data in Microbiology Online (http://mic.sgmjournals.org).
Analogues of the antibiotic thiolactomycin (TLM) have been synthesized and have been shown to have enhanced activity against whole cells of Mycobacterium tuberculosis H37Rv and against mycolic acid biosynthesis in cell extracts of Mycobacterium smegmatis. TLM has a methyl-branched butadienyl side chain attached at position 5 on a ‘thiolactone’ ring, namely 4-hydroxy-3,5-dimethyl-5H-thiophen-2-one. Various combinations of strong bases were explored to create a reactive anion at position 5 on the thiolactone ring which could react with halides to produce 5-substituted derivatives; the best reagent was two equivalents of lithium-bis-(trimethylsilyl)amide in tetrahydrofuran. The analogue with a 5-tetrahydrogeranyl substituent showed the best biological activity with an MIC90 for M. tuberculosis of 29 μM and 92% mycolate inhibition in extracts of M. smegmatis, as compared to 125 μM and 54%, respectively, for TLM; other related C10 and C15 isoprenoid derivatives had similar biological activity. These isoprenoid-based derivatives did not inhibit type II fatty acid synthase from M. smegmatis, but compounds with iso-butyl and iso-butenyl side chains did show some inhibitory activity against this enzyme. These short-chain derivatives did not inhibit mycolate synthesis or have significant antibiotic activity. Treatment of the thiolactone with a weaker base, sodium hydride in tetrahydrofuran, gave 3-alkyl-3,5-dimethyl-thiophene-2,4-dione analogues, which had no effect on fatty acid or mycolate synthesis. However, the geranyl derivative had an MIC99 of 60 μM for M. tuberculosis, one quarter that (240 μM) of TLM, demonstrating its excellent antibiotic potential against an unknown cellular target.
ChambersM. S.,
ThomasE. J.
1997; Asymmetric synthesis of 5,5-disubstituted thiotetronic acids using an allyl xanthate to dithiocarbonate rearrangement: total synthesis of (5 S) -thiolactomycin with revision of the absolute configuration of the natural product. J Chem Soc Perkin Trans I 417–431
HayashiT,
YamamotoO,
SasakiH,
KawaguchiA.,
OkazakiH.
1983; Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli
. Biochem Biophys Res Commun 115:1108–1113
JonesA. L,
DancerJ. E.,
HarwoodJ. L.
1994; The effect of thiolactomycin analogues on fatty acid synthesis in peas ( Pisum sativum cv. Onward). Biochem Soc Trans 22:258S
JonesA. L,
HerbertD,
RutterA. J,
DancerJ. E.,
HarwoodJ. L.
2000; Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea ( Pisum sativum)
. Biochem J 347:205–209
KremerL,
DouglasJ. D,
BaulardA. R.9 other authors2000; Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis
. J Biol Chem 275:16857–16864
MiyakawaS,
SuzukiK,
NotoT,
HaradaY.,
OkazakiH.
1982; Thiolactomycin, a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice. J Antibiot 35:411–419
OishiH,
NotoT,
SasakiH,
SuzukiK,
HayashiT,
OkazakiH,
AndoK.,
SawadaM.
1982; Thiolactomycin, a new antibiotic. I. Taxonomy of the producing organism, fermentation and biological properties. J Antibiot 35:391–395
PriceA. C,
ChoiK. H,
HeathR. J,
LiZ,
WhiteS. W.,
RockC. O.
2001; Inhibition of β-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism. J Biol Chem 276:6551–6559
SakyaS. M,
Suarez-ContrerasM,
DirlamJ. P,
O’ConnellT. N,
HayashiS. F,
SantoroS. L,
KamickerB. J,
GeorgeD. M.,
ZieglerC. B.
2001; Synthesis and structure–activity relationships of thiotetronic acid analogues of thiolactomycin. Bioorg Med Chem Lett 11:2751–2754
SlaydenR. A,
LeeR. E,
ArmourJ. W,
CooperA. M,
OrmeI. M,
BrennanP. J.,
BesraG. S.
1996; Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis. Antimicrob Agents Chemother 40:2813–2819
WallerR. F,
KeelingP. J,
DonaldR. G.7 other authors1998; Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
. Proc Natl Acad Sci USA 95:12352–12357
WheelerP. R,
BesraG. S,
MinnikinD. E.,
RatledgeC.
1993aStimulation of mycolic acid biosynthesis by incorporation of cis -tetracos-5-enoic acid in a cell-wall preparation from Mycobacterium smegmatis Biochim Biophys Acta; 1167182–188
WheelerP. R,
BesraG. S,
MinnikinD. E.,
RatledgeC.
1993b; Inhibition of mycolic acid biosynthesis in a cell-wall preparation from Mycobacterium smegmatis by methyl 3-(2-octadecylcyclopropen-1-yl) butanoate, a structural analogue of a key precursor. Lett Appl Microbiol 17:33–36
Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activityaaDetails for the preparation of the thiolactomycin analogues shown in Table 1 are available as supplementary data in Microbiology Online (http://mic.sgmjournals.org).